Display Settings:

Format

Send to:

Choose Destination
    Cancer Cells. 1990 Jun;2(6):163-71.

    Current status of cancer drug development: failure or limited success?

    Source

    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.

    Abstract

    Murine leukemia models have been a major part of cancer drug screening strategies over the past 30 years. While these models have reliably identified agents active against human leukemias and lymphomas, they have been considerably less effective in identifying new agents for the treatment of common human solid tumors. This review considers the shortcomings of past approaches to cancer drug development, and describes new screening strategies designed to identify carcinoma-selective drugs.

    PMID:
    2201343
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk